Jane Street Group, LLC Dyne Therapeutics, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 128,290 shares of DYN stock, worth $1.47 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,290
Previous 104,517
22.75%
Holding current value
$1.47 Million
Previous $3.75 Million
19.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding DYN
# of Institutions
212Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$91.8 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$84.6 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$84.5 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$76.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$73.1 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $593M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...